These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18996116)

  • 1. Attenuation of diabetes-induced retinal vasoconstriction by a thromboxane receptor antagonist.
    Wright WS; Messina JE; Harris NR
    Exp Eye Res; 2009 Jan; 88(1):106-12. PubMed ID: 18996116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ozagrel attenuates early streptozotocin-induced constriction of arterioles in the mouse retina.
    Wright WS; Harris NR
    Exp Eye Res; 2008 Mar; 86(3):528-36. PubMed ID: 18262522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of streptozotocin-induced microvascular changes in the mouse retina with the endothelin receptor A antagonist atrasentan.
    Wang Z; Yadav AS; Leskova W; Harris NR
    Exp Eye Res; 2010 Nov; 91(5):670-5. PubMed ID: 20727883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ozagrel reverses streptozotocin-induced constriction of arterioles in rat retina.
    Lee S; Morgan GA; Harris NR
    Microvasc Res; 2008 Nov; 76(3):217-23. PubMed ID: 18718478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of 20-HETE attenuates diabetes-induced decreases in retinal hemodynamics.
    Wang Z; Yadav AS; Leskova W; Harris NR
    Exp Eye Res; 2011 Jul; 93(1):108-13. PubMed ID: 21658386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice.
    Lee S; Harris NR
    Microcirculation; 2008 Jul; 15(5):379-87. PubMed ID: 18574741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of DT-TX 30, a combined thromboxane synthase inhibitor and thromboxane receptor antagonist, on retinal vascularity in experimental diabetes mellitus.
    De La Cruz JP; Moreno A; Ruiz-Ruiz MI; Sánchez De La Cuesta F
    Thromb Res; 2000 Feb; 97(3):125-31. PubMed ID: 10680643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of retinal blood flow by kinin B₁ receptor in Streptozotocin-diabetic rats.
    Pouliot M; Hétu S; Lahjouji K; Couture R; Vaucher E
    Exp Eye Res; 2011 Jun; 92(6):482-9. PubMed ID: 21420952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal arteriolar hemodynamic response to an acute hyperglycemic provocation in early and sight-threatening diabetic retinopathy.
    Gilmore ED; Hudson C; Nrusimhadevara RK; Ridout R; Harvey PT; Mandelcorn M; Lam WC; Devenyi RG
    Microvasc Res; 2007 May; 73(3):191-7. PubMed ID: 17343879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of light-flicker-induced retinal vasodilation and retinal vascular caliber measurements in diabetes.
    Nguyen TT; Kawasaki R; Kreis AJ; Wang JJ; Shaw J; Vilser W; Wong TY
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5609-13. PubMed ID: 19643973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the inhibitory effects of the TXA2 receptor antagonist, vapiprost, and other antiplatelet drugs on arterial thrombosis in rats: possible role of TXA2.
    Takiguchi Y; Wada K; Nakashima M
    Thromb Haemost; 1992 Oct; 68(4):460-3. PubMed ID: 1448780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptozotocin-induced diabetes decreases conducted vasoconstrictor response in mouse cremaster arterioles.
    Rai A; Riemann M; Gustafsson F; Holstein-Rathlou NH; Torp-Pedersen C
    Horm Metab Res; 2008 Sep; 40(9):651-4. PubMed ID: 18792878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vapiprost, a novel thromboxane receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tissue-type plasminogen activator.
    Matsuno H; Uematsu T; Umemura K; Takiguchi Y; Wada K; Nakashima M
    Br J Pharmacol; 1992 Jul; 106(3):533-8. PubMed ID: 1387025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the thromboxane A2 receptor in the vasoactive response to ischemia-reperfusion injury.
    Mazolewski PJ; Roth AC; Suchy H; Stephenson LL; Zamboni WA
    Plast Reconstr Surg; 1999 Oct; 104(5):1393-6. PubMed ID: 10513923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tempol on diabetes-induced decreases in retinal blood flow in the mouse.
    Yadav AS; Harris NR
    Curr Eye Res; 2011 May; 36(5):456-61. PubMed ID: 21501080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probucol prevents the attenuation of β
    Mori A; Higashi K; Wakao S; Sakamoto K; Ishii K; Nakahara T
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1247-1253. PubMed ID: 28913547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenoceptor-mediated vasodilation of retinal blood vessels is reduced in streptozotocin-induced diabetic rats.
    Nakazawa T; Sato A; Mori A; Saito M; Sakamoto K; Nakahara T; Ishii K
    Vascul Pharmacol; 2008; 49(2-3):77-83. PubMed ID: 18585480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes-induced vascular dysfunction in the retina: role of endothelins.
    Deng D; Evans T; Mukherjee K; Downey D; Chakrabarti S
    Diabetologia; 1999 Oct; 42(10):1228-34. PubMed ID: 10525664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats.
    Mitsuhashi J; Morikawa S; Shimizu K; Ezaki T; Yasuda Y; Hori S
    Exp Eye Res; 2013 Jan; 106():64-73. PubMed ID: 23178551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of studies on metabolic and vascular regulatory changes in early diabetic retinopathy.
    Alder VA; Su EN; Yu DY; Cringle S; Yu P
    Aust N Z J Ophthalmol; 1998 May; 26(2):141-8. PubMed ID: 9630295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.